Oncologia |
Azacitidina |
|
|
100 mg |
Filed |
|
Oncologia |
Bendamustina |
|
|
25, 100mg |
Filed |
|
Oncologia |
Bendamustine RTU |
|
|
180 mg/ 4 ml, 100 mg/ 4 ml |
Filed |
|
Oncologia |
Bortezomib |
|
|
3.5 mg |
Filed |
|
Oncologia |
Cabazitaxel |
|
|
60 mg/ 1.5 ml |
Filed |
|
Oncologia |
Carfilzomib |
|
|
30 mg/ml, 60 mg/ml |
Filed |
|
Oncologia |
Decitabine |
|
|
50 mg |
Filed |
|
Oncologia |
Eribulin |
|
|
1 mg/2 ml |
En desarrollo |
|
Oncologia |
Fingolimod |
|
|
0.5 mg |
Filed |
|
Oncologia |
Fulvestrant |
|
|
50 mg/ml |
Filed |
|
Oncologia |
Fosaprepitant |
|
|
150 mg/ ml |
Filed |
|
Oncologia |
Liposomal Doxorubicin |
|
|
20 mg/10 ml ,50 mg/25 ml |
Filed |
|
Oncologia |
Palonosetron |
|
|
0.075 mg/5 ml, 0.25 mg/ 5 ml |
Filed |
|
Oncologia |
Pemetrexed |
|
|
100 mg, 500 mg, 1000 mg |
Filed |
|
Oncologia |
Plerixafor |
|
|
24 mg/1.2 ml |
Filed |
|
Oncologia |
Zoledronic Acid |
|
|
4 mg/5 ml, 5 mg/100 ml, 4 mg/100 ml |
Filed |
|
Oncologia |
Abiraterone |
|
|
250 mg |
Filed |
|
Oncologia |
Abiraterone |
|
|
500 mg |
En desarrollo |
|
Oncologia |
Capecitabine |
|
|
150 mg, 500 mg |
Filed |
|
Oncologia |
Dasatinib |
|
|
20, 50, 70, 80,100 and 140 mg |
Filed |
|
Oncologia |
Enzalutamide |
|
|
40 mg |
En desarrollo |
|
Oncologia |
Everolimus |
|
|
2.5, 5, 7.5, 10 mg |
En desarrollo |
|
Oncologia |
Lenalidomide |
|
|
2.5, 5, 10, 15, 20, 25 mg |
Filed |
|
Oncologia |
Lenvatinib |
|
|
4, 10 mg |
En desarrollo |
|
Oncologia |
Nilotinib |
|
|
150, 200 mg |
En desarrollo |
|
Oncologia |
Palbociclib |
|
|
75, 100, 125 mg |
Filed |
|
Oncologia |
Pomalidomide |
|
|
1,2,3,4 mg |
Filed |
|
Oncologia |
Imatinib Mesylate |
|
|
100 MG AND 400 MG |
Filed |
|
Oncologia |
Carmustine |
|
|
100 mg/vial |
Filed |
|
Oncologia |
Venetoclax |
|
|
10 mg, 50 mg and 100 mg |
Filed |
|
Oncologia |
Sorafenib |
|
|
200 mg |
Filed |
|
Oncologia |
Midostaurin |
|
|
25 mg |
Filed |
|
Oncologia |
Sunitinib Malate |
|
|
12.5 mg, 25 mg, 37.5 mg and 50 mg |
Filed |
|
Oncologia |
Nano Paclitaxel |
|
|
100mg |
En desarrollo |
|
Oncologia |
Axitinib |
|
|
1mg, 3mg, 5mg, 7mg |
En desarrollo |
|
Oncologia |
Cabozantinib |
|
|
20 mg, 40 mg and 60 mg |
En desarrollo |
|
Oncologia |
Sunitinib |
|
|
12.5Mg;25Mg;37.5Mg;50Mg |
Filed |
|
Oncologia |
Tofacitinib XR |
|
|
Tofacitinib XR |
En desarrollo |
|
Oncologia |
Pazopanib |
|
|
200 and 400 mg |
En desarrollo |
|
Oncologia |
Dimethyl Fumarate |
|
|
120mg, 240mg |
En desarrollo |
|
Oncologia |
Nintedanib |
|
|
100 mg & 150 mg |
En desarrollo |
|
Oncology / Acromegaly |
Octerotide |
|
|
10mg, 20mg & 30mg |
En desarrollo |
|
Oncology / Acromegaly |
Lanreotide |
|
|
60mg/0.2mL, 90mg/0.3mL and 120mg/0.5mL |
En desarrollo |
|
Sistema nervioso central |
Glatiramer |
|
|
20, 40 mg |
Filed |
|
Sistema nervioso central |
Sugammadex |
|
|
100 mg/ml |
Filed |
|
Sistema nervioso central |
Pregabalin |
|
|
25, 50, 75, 100, 150, 200, 225, 300 mg |
Filed |
|
Oncologia |
Fingolimod |
|
|
0.5 mg |
Filed |
|
Cardiovascular |
Fondaparinux |
|
|
2.5, 5, 7.5, 10mg |
Filed |
|
Oncologia |
Dimethyl Fumarate |
|
|
120mg, 240mg |
En desarrollo |
|
Cardiovascular |
Treprostinil |
|
|
1, 2.5, 5, 10mg/ml |
Filed |
|
Cardiovascular |
Apixaban |
|
|
2.5, 5mg |
Filed |
|
Cardiovascular |
Dabigatran |
|
|
75 , 110, 150 mg |
Filed |
|
Cardiovascular |
Rivaroxaban |
|
|
10, 15, 20 mg |
Filed |
|
Cardiovascular |
Sacubitril/ Valsartan |
|
|
24/26, 49/51, 97/103 mg |
Filed |
|
Cardiovascular |
Ticagrelor |
|
|
60, 90 mg |
Filed |
|
Cardiovascular |
Icosapent Ethy |
|
|
1 g |
Filed |
|
Anti-diabético |
Canagliflozin + Metformin |
|
|
150 mg/1000 mg, 150 mg/500 mg, 50mg/1000 mg, 50 mg/500 mg |
Filed |
|
Anti-diabético |
Linagliptin |
|
|
5 mg |
Filed |
|
Anti-diabético |
Linagliptin + Metformin |
|
|
2.5 mg/500 mg, 2.5 mg/850 mg, 2.5 mg/1000 mg |
Filed |
|
Anti-diabético |
Liraglutide |
|
|
6mg/ml – 3 ml fill pen |
En desarrollo |
|
Anti-diabético |
Semaglutide |
|
|
2mg/1.5mL; 4mg/3mL |
En desarrollo |
|
Anti-Obesity |
Liraglutide |
|
|
6mg/ml – 3 ml fill pen |
En desarrollo |
|
Gastro-Intestinal |
Esomeprazole |
|
|
20, 40mg |
Filed |
|
Gastro-Intestinal |
Esomeprazole MG + Naproxen Na |
|
|
20 mg/375 mg, 20 mg/500 mg |
Filed |
|
Gastro-Intestinal |
Lansoprazole ODT |
|
|
15 mg and 30 mg |
Filed |
|
Immuno Suppressant |
Sirolimus |
|
|
1 mg and 2 mg |
Filed |
|
Immuno Suppressant |
Tacrolimus |
|
|
0.5 mg, 1 mg and 5 mg |
Filed |
|
Otras |
Daptomycin |
|
|
350, 500 mg |
Filed |
|
Otras |
Icatibant |
|
|
30 mg base /3 ml PFS |
Filed |
|
Otras |
Iron Sucrose |
|
|
100 mg/5 ml, 200 mg/10 ml, 50 mg/2.5 ml |
Filed |
|
Otras |
阿普斯特 |
|
|
10, 20, 30 mg |
Filed |
|
Otras |
Sevelamer Carbonate |
|
|
800 mg |
Filed |
|
Otras |
Valganciclovir |
|
|
450 mg |
Filed |
|
Otras |
Isotretinoin |
|
|
10mg, 20mg, 30mg and 40mg |
Filed |
|
Otras |
Varenicline |
|
|
0.5 mg and 1 mg |
Filed |
|
Otras |
Ferric Carboxy Maltose |
|
|
50mg/mL |
En desarrollo |
|
Otras |
Teriparatide |
|
|
0.6 mg/2.4 mL (0.25 mg/mL) |
En desarrollo |
|
Otras |
Rifaximine |
|
|
550mg |
En desarrollo |
|
Otras |
Amphotericin B |
|
|
50mg |
En desarrollo |
|
Otras |
Mesalamine |
|
|
250 and 500 mg |
En desarrollo |
|